echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature sub-journal: New breakthrough in cancer immunotherapy, Stanford University finds new way to trigger antigens of specific immune cells

    Nature sub-journal: New breakthrough in cancer immunotherapy, Stanford University finds new way to trigger antigens of specific immune cells

    • Last Update: 2022-09-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Scientists develop new method to find antigens that trigger specific immune cells faster and more accurately

    The secrets of a cell can be revealed from its surface


    A team of scientists at Stanford University has developed a new method to more quickly and accurately predict which antigen will trigger a strong immune response


    T cells are a type of immune cell that crawls and squeezes past other cells as they patrol the body


    "T cells can detect an antigenic peptide among 10,000 to 100,000 non-antigenic peptides on the cell surface," said Fordyce, assistant professor of bioengineering and genetics


    The key to selectivity lies in the crawling of T cells


    Fordyce said


    imitation of cells

    Finding the optimal antigen-receptor pair requires simultaneously applying a sliding or shearing force between the peptide and T cells, and measuring T cell activation


    Postdoctoral scholar Yinnian Feng, the study's first author, developed a trick that allowed the research team to measure the interaction of 20 unique peptides with thousands of T cells in less than five hours


    To create a simplified system that mimics suspended polypeptide cells, they constructed small spherical beads of a material that expands when heated and attaches several molecules of a given polypeptide particle pMHCs to their surfaces


    They could run hundreds of separate experiments in parallel by using each unique color-labeled bead, which made it possible to track multiple different pMHCs


    In a demonstration of their platform, the research team showed 21 unique peptides, their results confirmed a T cell receptor known to activate and non-activating peptides, and revealed a previously unknown antigen that can induce strong T cellular response


    Using their technique, the research team characterized T-cell receptors that can specifically recognize tumor antigens without generating off-target responses


    Scientists hope that this method, which is fast and requires very few cells, or an optimized method, could one day be used to improve personalized immunotherapy


    Reference: Bead-based method for high-throughput mapping of the sequence- and force-dependence of T cell activation


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.